BioCentury
ARTICLE | Company News

Bayer submits Japanese application for riociguat

May 18, 2013 12:04 AM UTC

Bayer AG (Xetra:BAYN) submitted a regulatory application in Japan for riociguat to treat chronic thromboembolic pulmonary hypertension (CTEPH). The oral soluble guanylyl cyclase (sGC) stimulator is un...